Learn about MeMed's host
immune response technology at
Online 9 - 12 July 2021
MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.
Speaking on behalf of MeMed at the conference:
S116 Viral infections
Observer “A host assay comprising TRAIL, IP-10 and CRP can improve antibiotic treatment decisions for viral PCR positive adults by accurately ruling out co-infection”
Dr. Eran Eden
Co-founder and CEO of MeMed
09 July 2021 - 19:25
S36 Bacterial infection
Autopilot: “A host-based assay comprising TRAIL, IP-10 and CRP outperforms procalcitonin in accurately distinguishing bacterial from viral infections in febrile children”
Prof. Susanna Esposito
Full Professor of Pediatrics
Prof. Susanna Esposito, Full Professor of Pediatrics, Director of Pediatric Clinic, Pietro Barilla Children’s Hospital, Director of Specialization School in Pediatrics, Department of Medicine and Surgery, University
10 July 2021 - 17:25
At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.
Importantly, with the support of public and private partnerships, we have developed a point-of-need, rapid measurement platform called MeMed Key® to ensure timely availability of these novel tests during the clinician’s decision-making workflow.